Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program

被引：0
|
作者：
Desai, AS
Swedberg, K
Mcmurray, JJV
Granger, CB
Yusut, S
Young, JB
Dunlap, ME
Solomon, SD
Hainer, JW
Olotsson, B
Michelson, EL
Pfeffer, MA
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Sahlgrens Univ Hosp, Gothenburg, Sweden
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52A / 52A
页数：1
相关论文
共 50 条
  • [41] Atrial fibrillation carries similar risks in heart failure irrespective of ejection fraction-results from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)
    Olsson, L. G.
    Swedberg, K.
    Granger, C. B.
    Michelson, E.
    McMurray, J. J. V.
    Puuh, M.
    Yusuf, S.
    Pfeffer, M. A.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 378 - 379
  • [42] Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme
    Hawkins, NM
    Wang, DL
    Pocock, SJ
    McMurray, JJV
    Pfeffer, MA
    Swedberg, K
    Granger, CB
    Yusuf, S
    Dunn, FG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 146A - 146A
  • [43] Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme
    Chang, Su Min
    Granger, Christopher B.
    Johansson, Peter A.
    Kosolcharoen, Peter
    McMurray, John J. V.
    Michelson, Eric L.
    Murray, David R.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Solomon, Scott D.
    Swedberg, Karl
    Yusuf, Salim
    Dunlap, Mark E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (07) : 738 - 745
  • [44] Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Olsson, Lars G.
    Swedberg, Karl
    Ducharme, Anique
    Granger, Christopher B.
    Michelson, Eric L.
    McMurray, John J. V.
    Puu, Margareta
    Yusuf, Salim
    Pfeffer, Marc A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) : 1997 - 2004
  • [45] The risk associated with diabetes mellitus in patients with preserved and low ejection fraction heart failure. An analysis of the candesartan in heart failure: Assessment of reduction in mortality and morbidity programme
    MacDonald, M.
    Varyani, F.
    Carlsson, J.
    Petrie, M.
    Ostergren, J.
    Michelson, E.
    Solomon, S.
    Granger, C.
    Swedberg, K.
    Pfeffer, M.
    Yusuf, S.
    McMurray, J.
    [J]. HEART, 2007, 93 : A40 - A41
  • [46] Candesartan and heart failure: the allure of CHARM
    White, HD
    [J]. LANCET, 2003, 362 (9386): : 754 - 755
  • [47] Predictors of mortality and morbidity in patients with chronic heart failure
    Pocock, SJ
    Wang, DL
    Pfeffer, MA
    Yusuf, S
    McMurray, JJV
    Swedberg, KB
    Östergren, J
    Michelson, EL
    Pieper, KS
    Granger, CB
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (01) : 65 - 75
  • [48] Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: The CHARM Program
    Mitchell, GF
    Arnold, JMO
    Dunlap, ME
    O'Brien, TX
    Marchiori, G
    Warner, E
    Granger, CB
    Desai, SS
    Pfeffer, MA
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (02) : 191 - 197
  • [49] Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the candesartan in heart failure:: Assessment of reduction in mortality and morbidity (CHARM)-Added trial
    McMurray, JJV
    Young, JB
    Dunlap, ME
    Granger, CB
    Hainer, J
    Michelson, EL
    Earle, S
    Olofsson, B
    Östergren, J
    Yusuf, S
    Swedberg, K
    Pfeffer, MA
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (05) : 985 - 991
  • [50] Kardioprotektion durch Candesartan bei HerzinsuffizienzCHARM-overall-Teilauswertung (Candesartan in heart failure assessment of reduction in mortality and morbidity)
    C. Tschöpe
    H. P. Schultheiss
    [J]. Der Internist, 2006, 47 : 1084 - 1086
12345